Chemicals produced by fires show potential to raise cancer risk
Simulations reveal PAHs’ affinity for binding to DNA — and evading repair — in study co-led by a county firefighter.
cancer
Results
UCLA team develops a platform that mimics nature to enhance T cell-based therapies
Immune-based treatment gets a boost to its cancer-fighting superpowers.
Unlocking the potential of patient-derived ‘organoids’ for personalized sarcoma treatment
Using small 3D models that mimic a patient’s tumor, UCLA researchers can quickly test hundreds of potential drugs.
UCLA scientists uncover limits of metabolic flexibility in a skin cancer
A new study suggests combination therapies could overcome tumor adaptability.
Novel procedure helps treat renowned chef’s rare eye cancer
A minimally invasive approach gives a better treatment option to certain patients with metastatic uveal melanoma.
12 years after a terminal prognosis, Maui attorney gives others hope
A UCLA-developed vaccine helped Jamil Newirth beat brain cancer and thrive in law and philanthropy.
UCLA oncologist Dennis Slamon awarded Szent-Györgyi Prize
Slamon’s innovations, including his work developing the breast cancer drug Herceptin, helped shape a new era in cancer therapy.
Scientists identify ‘missing piece’ required for blood stem cell self-renewal
The study could help make lifesaving stem cell transplants more available.
Novel technology positions ‘off-the-shelf’ cancer immunotherapy for the clinic
UCLA scientists develop a new method to engineer immune cells that could treat multiple patients.
Mutations in noncoding DNA become functional in some cancer-driving genes
These regions of the gene alter the abundance of mRNA and the proteins it instructs the cell to make.
‘I feel like myself again’: UCLA clinical trial offers hope for lymphoma patients
Hirotaka Matsunaga has been in remission for 18 months after participating in an experimental CAR-T cell therapy led by UCLA professors.
3 strategies to break down barriers to breastfeeding and lower women’s risk of breast cancer
UCLA Center for Health Policy Research report recommends changes to laws and a more diverse lactation consultant workforce.
The UCLA Research Park: Immunology and immunotherapy
At the new research park, the California Institute for Immunology and Immunotherapy at UCLA is poised to enter a new era of biomedical breakthroughs.
UCLA chemists use oxygen, copper ‘scissors’ to make cheaper drug treatments possible
The groundbreaking process cuts carbon bonds to convert organic molecules into biologically active amine molecules.
Hospitals serving large Black, Latino populations have fewer resources for cancer care
A UCLA study shows these facilities are much less likely than others to offer the full range of core cancer services.
Can cannabis-based meds help people manage oral cancer pain?
A UCLA Dentistry–led team has received a $5 million federal grant to develop an effective, non-addictive synthetic cannabinoid.
Study could help explain why certain brain tumors don’t respond well to immunotherapy
Immune checkpoint blockade has been ineffective for treating glioblastoma; UCLA-led research may reveal why.
Immunotherapy drug combo helps extend lives of people with metastatic melanoma
The finding is from a multicenter study co-led by Dr. Antoni Ribas and a team of UCLA researchers.
Cost of translating documents could be a barrier to underrepresented groups in clinical trials
A UCLA study identified an “addressable weakness” related to patient consent paperwork.
New drug delays progression of glioma, a deadly brain cancer
A study co-led by UCLA is the first clinical trial analyzing a targeted therapy specifically developed to treat brain tumors.
A metabolic process in cancer cells could unlock a possible treatment for glioblastoma
A UCLA-led study could lead to a new strategy for treating the aggressive form of brain cancer.
$5 million gift from Nancy and Howard Marks endows chair in women’s health research at UCLA
The inaugural chair holder is Dr. Beth Karlan, a UCLA professor of obstetrics and gynecology.
UCLA study on immune cell response could lead to more effective immunotherapy
Jonsson Comprehensive Cancer Center scientists adapted advanced gene-editing technology to make their observations.
Tiny implantable device designed by UCLA scientists helps kill cancer
A therapeutic sponge the size of a pencil eraser boosted tumor-fighting responses in mice and kept cancer from returning.